Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II

This trial assesses the wear performance of the Zio monitor, a long-term continuous ambulatory patch ECG monitor, in a representative population by evaluating (1) the wear duration (up to 30 days) of the device, (2) the percentage of analyzable electrocardiographic time and (3) safety by reviewing all adverse events.

NCT Number	NCT07205367
Lead Sponsor	iRhythm Technologies, Inc.
Conditions	Cardiac Arrhythmia
Enrollment	150 participants
Start Date	2025-01-06
Primary Completion	2025-07-29 (estimated)
Study Completion	2025-11-07 (estimated)
Updated on ClinicalTrials.gov	2026-08-05